Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples
Cancers · 27.01.2025 · 17 (3) · 427
DOI: 10.3390/cancers17030427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 27.01.2025. Verfasst von Lucreția Avram und 9 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics-Gerontology, Department 5-Medical Specialties, Faculty of Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, 400…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Colorectal cancer (CRC) represents one of the most prevalent forms of cancer, with high mortality rates. The aim of this study was to observe and understand the metabolic changes in CRC through targeted metabolomics.
Methods
Samples collected from 58 CRC patients and 35 healthy individuals have been analyzed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS), targeting two classes of metabolites: amino acids and acylcarnitines.
Results
Statistical analysis revealed 26 significantly modified (p-value < 0.01; |FC| > 1.2) metabolites in CRC patients compared to the control group and 22 between colon cancer and control, whereas 8 metabolites differed only significantly between rectal cancer and healthy patients. Some of these significantly modified metabolites characterize cancer-specific adaptations, such as increased energy demand, increased tumor invasiveness, capabilities to promote amino acid synthesis, and tumor resistance against acute immune response. Moreover, receiver operator characteristic (ROC) analysis revealed that a set of two acylcarnitines (C6DC and C4-OH) can differentiate between CRC patients and healthy individuals with a high degree of confidence (AUC 0.837).
Conclusions
By implementing a metabolomics approach targeting amino acids and acylcarnitines, several metabolic alterations induced by CRC have been highlighted. Even though these modifications are not specific enough to act as disease markers, they might prove useful for evaluating patient status.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geriatrics-Gerontology, Department 5-Medical Specialties, Faculty of Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.
- Department of Internal Medicine, 5th Medical Clinic, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.
- Department of Personalized Medicine and Rare Diseases, Institute of Biomedical Research-MedFuture, "Iuliu Hațieganu" University of Medicine and Pharmacy Cluj-Napoca, 400012 Cluj-Napoca, Romania.
- Department of Pharmaceutical Analysis, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- 1st Surgical Clinic, Department of General Surgery, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj Napoca, Romania.
- Intensive Care Unit Department, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Lucreția Avram, Radu-Cristian Moldovan, Cristina-Adela Iuga
Zitieren
APA
Avram, L., Crișan, D., Moldovan, R. C., Bogos, L. G., Iuga, C. A., Andraș, D., Crișan, S., Bodolea, C., Nemeş, A., & Donca, V. (2025). Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples. Cancers, 17(3), 427. https://doi.org/10.3390/cancers17030427
Vancouver
Avram L, Crișan D, Moldovan RC, Bogos LG, Iuga CA, Andraș D, et al. Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples. Cancers. 2025;17(3):427. doi:10.3390/cancers17030427
BibTeX
@article{Avram2025,
author = {Avram, Lucreția and Crișan, Dana and Moldovan, Radu-Cristian and Bogos, Luisa-Gabriela and Iuga, Cristina-Adela and Andraș, David and Crișan, Sorin and Bodolea, Constantin and Nemeş, Andrada and Donca, Valer},
title = {Metabolomic Exploration of Colorectal Cancer Through Amino Acids and Acylcarnitines Profiling of Serum Samples},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {427},
doi = {10.3390/cancers17030427}
}
EUVIMED